Plain-English translation of NCT06626438 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to care for people with interstitial lung disease—a serious lung condition involving scarring. Instead of seeing just a lung specialist, you would meet with a team of healthcare professionals (a nurse, physiotherapist, psychologist, dietician, and lung doctor) who work together to create a personalized treatment plan for you. The study will compare this team-based approach to standard care to see which helps patients feel better and have better quality of life.
Many people with lung fibrosis struggle with multiple symptoms and problems at the same time—like breathing difficulty, cough, fatigue, depression, and poor nutrition—but don't always receive coordinated care to address all of these. Researchers believe that having a whole team work together to spot and treat these different problems might help patients do better than seeing a lung doctor alone.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either the new team-based clinic or standard care. At the team clinic, you'll have one visit where you meet separately with different specialists (nurse, physiotherapist, psychologist, dietician, and lung doctor) who then meet together to design a personalized care plan just for you. You'll also complete several questionnaires about your symptoms, mood, and quality of life, and have lung function tests, blood work, and possibly scans. The study team will then track how you do over time, measuring your quality of life, how your disease progresses, and any hospitalizations.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Australia